Sustained release intranasal formulation and method of use thereof
Patent 4581225 Issued on April 8, 1986. Estimated Expiration Date: 
January 28, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
January 28, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesInventorsAssigneeApplicationNo. 06/695491 filed on 01/28/1985US Classes:424/45Organic pressurized fluidExaminersPrimary: Rose, Shep K.Attorney, Agent or FirmInternational ClassesA61K 9/00 (20060101)A61K 47/14 (20060101) A61K 31/135 (20060101) A61K 47/12 (20060101) AbstractAdministration of a catecholamine by a novel intranasal delivery system provides prolonged blood levels of the drug.Field of SearchOrganic pressurized fluid | |
